Inceptua Group Acquires SupplyRx to Expand Clinical Trial Pharmacy Services

September 2, 2026

Inceptua Group, backed by Vesey Street Capital Partners, announced it has acquired SupplyRx, a U.S.-based technology-driven provider of cloud-based digital solutions for clinical trial pharmacy programs in the U.S. and Canada. The acquisition is intended to strengthen Inceptua’s pharmacy model by adding SupplyRx’s portal technology, networks, and processes to improve the clinical supply chain and patient access.

Buyers
Inceptua Group, Vesey Street Capital Partners
Targets
SupplyRx, Inc.
Location
North Carolina, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.